Capital MarketsGreater ChinaCapital Markets

Yuanli Lingji Merges with Atomix, Closes Strategic Funding Round

Embodied intelligence firm Yuanli Lingji acquired logistics robotics company Atomix via equity swap. It also secured strategic financing from Zhipu, StepFun, and SenseTime.

The merger between Yuanli Lingji and Atomix, completed through an equity swap, is not simply a combination of two startups. It represents a deliberate bet on the convergence of two previously distinct domains: high-level AI reasoning and physical logistics execution. Yuanli Lingji, an embodied intelligence firm focused on robotic manipulation and perception, has effectively absorbed Atomix, a specialist in warehouse automation.

At the same time, the merged entity has secured strategic financing from Zhipu, StepFun, and SenseTime—three of China’s most prominent AI and computer vision players. This is not a rescue deal. Atomix brings a proven hardware platform and a roster of logistics clients, while Yuanli Lingji contributes the software and AI stack needed to make those robots think on the fly. The equity swap structure suggests both sets of shareholders see greater value in integration than in operating separately.

In a market where dozens of robotics startups chase similar warehouse contracts, scale and vertical integration are becoming decisive advantages. The involvement of Zhipu, StepFun, and SenseTime as strategic investors adds another layer. These are not passive capital providers. Each brings deep expertise in large language models, multimodal perception, and edge computing.

Their participation signals that the merged company intends to embed generative AI directly into robotic control systems—not just for navigation, but for real-time decision-making in cluttered, dynamic warehouse environments. What a casual observer might miss is the timing. This deal closes just as China’s logistics sector faces a structural labor shortage and rising demand for same-day delivery. The country’s warehouse robotics market is still fragmented, with dozens of players offering narrow solutions.

Yuanli Lingji’s move suggests a belief that the next phase of competition will favor companies that can offer both the brain and the brawn—AI-driven manipulation and reliable hardware deployment under one roof. The financing round also reflects a shift in investor sentiment. After years of hype around humanoid robots and general-purpose machines, the market is rewarding companies that can demonstrate near-term commercial viability. Warehouse automation is one of the few robotic applications with clear ROI metrics.

By combining Yuanli Lingji’s AI layer with Atomix’s installed base, the merged entity can pitch a more compelling value proposition to logistics operators. Still, integration will not be seamless. Merging engineering cultures, aligning product roadmaps, and retaining talent are non-trivial challenges. The equity swap structure means both sides have skin in the game, but execution risk remains.

The strategic investors will likely push for rapid deployment of AI features into Atomix’s existing systems, which could strain development timelines. What happens next will depend on whether the combined team can deliver a unified product that outperforms the sum of its parts. If they succeed, this deal could become a template for consolidation in China’s embodied robotics space. If not, it will be remembered as a well-financed experiment that failed to scale.

The market is watching for the first integrated system to roll out in a major warehouse—that moment will tell more than any press release.

Related Coverage

More from this story

Greater China / Capital MarketsHSBC Jintrust Struggles as Past Equity Strength FadesGreater China / Capital MarketsYuanli Lingji Merges with Atomix, Closes Strategic Round from Zhipu, StepFun, SenseTimeChina / Capital MarketsOrigin Quantum closes nearly 3 bln yuan Pre-IPO round at 21 bln valuationChina / Capital MarketsOrigin Quantum Raises 3 Billion Yuan in Pre-IPO Round at 21 Billion ValuationHong Kong / Capital MarketsTianchen Biotech surges 50% on HKEX debut, nears HKD 10 billion market cap